BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18158579)

  • 21. A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
    Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A
    Cytometry B Clin Cytom; 2013 Mar; 84(2):71-81. PubMed ID: 23281097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
    Piedras J; López-Karpovitch X
    Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
    Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
    Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.
    Tembhare P; Ramani M; Syed K; Gupta AD
    Indian J Pathol Microbiol; 2010; 53(4):699-703. PubMed ID: 21045396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.
    Sugimori C; Mochizuki K; Qi Z; Sugimori N; Ishiyama K; Kondo Y; Yamazaki H; Takami A; Okumura H; Nakao S
    Br J Haematol; 2009 Oct; 147(1):102-12. PubMed ID: 19656154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria].
    Gao W; Wang Z; Zhou Y
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):740-3. PubMed ID: 11930678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.
    Meletis J; Terpos E; Samarkos M; Meletis C; Konstantopoulos K; Komninaka V; Apostolidou E; Benopoulou O; Korovesis K; Mavrogianni D; Variami E; Yataganas X; Loukopoulos D
    Haematologia (Budap); 2001; 31(1):7-16. PubMed ID: 11345408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value].
    Sanz GF; Sanz MA; Vallespí T; Cañizo MC; García S; Torrabadella M; San Miguel JF; Irriguible D
    Sangre (Barc); 1989 Feb; 34(1):41-6. PubMed ID: 2711284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
    Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
    Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.
    Kolb HJ; Holler E; Bender-Götze C; Walther U; Mittermüller J; Clemm C; Bauchinger M; Gerhartz HH; Brehm G; Ledderose G
    Bone Marrow Transplant; 1989 Jan; 4(1):29-34. PubMed ID: 2647184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplastic syndrome: a review from University Hospital, Kuala Lumpur.
    Ng SC; Kuperan P; Bosco J; Menaka N
    Singapore Med J; 1990 Apr; 31(2):153-8. PubMed ID: 2196685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing PNH with FLAER and multiparameter flow cytometry.
    Sutherland DR; Kuek N; Davidson J; Barth D; Chang H; Yeo E; Bamford S; Chin-Yee I; Keeney M
    Cytometry B Clin Cytom; 2007 May; 72(3):167-77. PubMed ID: 17285629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
    Alfinito F; Del Vecchio L; Rocco S; Boccuni P; Musto P; Rotoli B
    Leukemia; 1996 Aug; 10(8):1326-30. PubMed ID: 8709638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of PIG-A gene in a patient who developed reciprocal translocation of chromosome 12 and paroxysmal nocturnal hemoglobinuria during follow-up of aplastic anemia.
    Nishimura JI; Inoue N; Azenishi Y; Hirota T; Akaogi T; Shibano M; Kawagoe K; Ueda E; Machii T; Takeda J
    Am J Hematol; 1996 Mar; 51(3):229-33. PubMed ID: 8619404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings.
    Rigolin GM; Porta MD; Bugli AM; Castagnari B; Mauro E; Bragotti LZ; Ciccone M; Cuneo A; Castoldi G
    Eur J Haematol; 2004 Nov; 73(5):351-8. PubMed ID: 15458514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
    Shikama Y; Shichishima T; Ohto H; Jubinsky PT; Maruyama Y
    Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelodysplastic syndromes (MDS) in Zimbabweans--preliminary observations.
    Mukiibi JM; Paul B
    East Afr Med J; 1989 Mar; 66(3):155-61. PubMed ID: 2591323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal hemoglobinuria.
    Gupta R; Pandey P; Choudhry R; Kashyap R; Mehrotra M; Naseem S; Nityanand S
    Int J Lab Hematol; 2007 Apr; 29(2):119-26. PubMed ID: 17474884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.